A Treat-To-Target Strategy With Methotrexate and Intra-Articular Triamcinolone With Or Without Added Adalimumab Reduces Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression In Early Rheumatoid Arthritis: The Opera Magnetic Resonance Imaging Sub-Study

被引：0

作者：

Axelsen, Mette Bjorndal ^{[1
]}

Eshed, Iris ^{[2
]}

Horslev-Petersen, Kim ^{[3
]}

Steengaard-Petersen, Kristian ^{[4
]}

Hetland, Merete L. ^{[5
]}

Moller, Jakob M. ^{[6
]}

Junker, Peter ^{[7
]}

Podenphant, Jan ^{[8
]}

Ellingsen, Torkell ^{[9
]}

Ahlquist, Palle ^{[10
]}

Lindegaard, Hanne M. ^{[7
]}

Linauskas, Asta ^{[11
]}

Schlemmer, Annette ^{[12
]}

Dam, Mette Yde ^{[13
]}

Hansen, Ib ^{[14
]}

Horn, Hans Chr ^{[15
]}

Ammitzboll, Christian G. ^{[4
]}

Jorgensen, Anette ^{[4
]}

Krintel, Sophine B. ^{[16
]}

Raun, Johnny ^{[17
]}

Johansen, Julia S. ^{[18
]}

Krogh, Niels Steen ^{[19
]}

Ostergaard, Mikkel ^{[5
]}

机构：

[1] Univ Copenhagen, Copenhagen, Denmark

[2] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel

[3] South Jutland Hosp, Graasteen, Denmark

[4] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark

[5] Copenhagen Univ Hosp Glostrup, Copenhagen, Denmark

[6] Copenhagen Univ Hosp Herlev, Copenhagen, Denmark

[7] Odense Univ Hosp, DK-5000 Odense C, Denmark

[8] Copenhagen Univ Gentofte, Hellerup, Denmark

[9] Diagnost Ctr Reg Hosp, DK-8600 Silkeborg, Denmark

[10] Vejle Reg Hosp, Vejle, Denmark

[11] Vendsyssel Hosp, Hjorring, Denmark

[12] Aalborg Univ Hosp, Aalborg, Denmark

[13] Silkeborg Reg Hosp, Silkeborg, Denmark

[14] Viborg Hosp, Viborg, Denmark

[15] Vejle Hosp, Vejle, Denmark

[16] Copenhagen Univ Hosp, Glostrup, Denmark

[17] Univ Southern Denmark, Grasten, Denmark

[18] Herlev Hosp, DK-2730 Herlev, Denmark

[19] ZiteLab ApS, Copenhagen, Denmark

来源：

ARTHRITIS AND RHEUMATISM | 2013年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2802

引用

页码：S1199 / S1199

页数：1

共 6 条

[1] A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial
Axelsen, Mette Bjorndal
Eshed, Iris
Horsley-Petersen, Kim
Stengaard-Pedersen, Kristian
Hetland, Merete Lund
Moller, Jakob
Junker, Peter
Podenphant, Jan
Schlemmer, Annette
Ellingsen, Torkell
Ahlquist, Palle
Lindegaard, Hanne
Linauskas, Asta
Dam, Mette Yde
Hansen, Ib
Horn, Hans Christian
Ammitzboll, Christian Gytz
Jorgensen, Anette
Krintel, Sophine B.
Raun, Johnny
Krogh, Niels S.
Johansen, Julia Sidenius
Ostergaard, Mikkel
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (05) : 867 - 875
[2] EFFECTS OF ADALIMUMAB ADDED TO TREAT-TO-TARGET STRATEGY WITH METHOTREXATE AND INTRA-ARTICULAR TRIAMCINOLONE ON LIPIDS IN EARLY- AND TREATMENT NAIVE RHEUMATOID PATIENTS: SECONDARY ANALYSES FROM THE MULTICENTER DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED OPERA TRIAL
Masic, D.
Stengaard-Pedersen, K.
Logstrup, B. B.
Horslev-Petersen, K.
Hetland, M. L.
Junker, P.
Ostergaard, M.
Ammitzbol, C.
Moller, S.
Christensen, R.
Ellingsen, T.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 607 - 607
[3] Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
Horslev-Petersen, Kim
Hetland, Merete Lund
Junker, Peter
Podenphant, Jan
Ellingsen, Torkell
Ahlquist, Palle
Lindegaard, Hanne
Linauskas, Asta
Schlemmer, Annette
Dam, Mette Yde
Hansen, Ib
Horn, Hans Christian
Ammitzboll, Christian Gytz
Jorgensen, Anette
Krintel, Sophine B.
Raun, Johnny
Johansen, Julia S.
Ostergaard, Mikkel
Stengaard-Pedersen, Kristian
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) : 654 - 661
[4] Adalimumab Added to a Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone in Early Rheumatoid Arthritis Increased Remission Rates, Function and Quality of Life. The OPERA Study: An Investigator-Initiated, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Trial
Lunzer, R.
JOURNAL FUR MINERALSTOFFWECHSEL, 2013, 20 (03): : 116 - 117
[5] Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA)
Moller-Bisgaard, S.
Ejbjerg, B. J.
Eshed, I.
Horslev-Petersen, K.
Hetland, M. L.
Jurik, A. G.
Thomsen, H.
Torfing, T.
Stengaard-Pedersen, K.
Junker, P.
Krogh, N. S.
Lottenburger, T.
Ellingsen, T.
Andersen, L. S.
Skjodt, H.
Svendsen, A. J.
Tarp, U.
Hansen, I. T.
Podenphant, J.
Pedersen, J. K.
Lindegaard, H.
Hanson, L. G.
Vestergaard, A.
Glinatsi, D.
Ostergaard, M.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 335 - 345
[6] Induction Therapy With Adalimumab On Top Of An Aggressive Treat-To-Target Strategy With Methotrexate and Intraarticular Corticosteroid Reduces Radiographic Erosive Progression In Early Rheumatoid Arthritis, Even After Withdrawal Of Adalimumab. Results Of a 2-Year Trial (OPERA).
Horslev-Petersen, Kim
Ornbjerg, Lykke Midtboll
Hetland, Merete L.
Junker, Peter
Podenphant, Jan
Ellingsen, Torkell
Ahlqvist, Palle
Lindegaard, Hanne M.
Linauskas, Asta
Schlemmer, Annette
Dam, Mette Y.
Hansen, Ib
Lottenburger, Tine
Jorgensen, Anette
Krintel, Sophine B.
Raun, Johnny
Ammitzboll, Christian G.
Johansen, Julia
Ostergaard, Mikkel
Stengaard-Pedersen, Kristian
ARTHRITIS AND RHEUMATISM, 2013, 65 : S600 - S601

← 1 →